SML2522
Diprovocim-1
≥98% (HPLC)
Synonym(s):
(3S,3′S,4S,4′S)-1,1′-(1,4-Phenylenedicarbonyl)bis[N-[(1S,2R)-2-phenylcyclopropyl]-3,4-pyrrolidinedicarboxamide, 3,4-Pyrrolidinedicarboxamide, 1,1′-(1,4-phenylenedicarbonyl)bis[N-[(1S,2R)-2-phenylcyclopropyl]-, (3S,3′S,4S,4′S)-
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C56H56N6O6
CAS Number:
Molecular Weight:
909.08
UNSPSC Code:
51111800
NACRES:
NA.77
Assay:
≥98% (HPLC)
Form:
powder
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
SMILES string
N7(C[C@H]([C@@H](C7)C(=O)N[C@@H]%10[C@H](C%10)c%11ccccc%11)C(=O)N[C@@H]8[C@H](C8)c9ccccc9)C(=O)c1ccc(cc1)C(=O)N2C[C@H]([C@@H](C2)C(=O)N[C@@H]5[C@H](C5)c6ccccc6)C(=O)N[C@@H]3[C@H](C3)c4ccccc4
InChI key
ABZBNXFGYUSVCJ-UYMKNZQYSA-N
Biochem/physiol Actions
Agonist of toll-like receptors TLR2 and TLR1
Diprovocim-1 is a potent agonist of toll-like receptors TLR2 and TLR1 with an EC50 value of 100 pM. Diprovocim-1 was shown to synergize with anti-PD-L1 treatment, inhibiting tumor growth, generating long-term antitumor memory, and curing or prolonging survival of mice engrafted with the murine melanoma B16-OVA.
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Ying Wang et al.
Proceedings of the National Academy of Sciences of the United States of America, 115(37), E8698-E8706 (2018-08-29)
Successful cancer immunotherapy entails activation of innate immune receptors to promote dendritic cell (DC) maturation, antigen presentation, up-regulation of costimulatory molecules, and cytokine secretion, leading to activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs). Here we screened a synthetic library